Building on the success of the first GU Cancer Triad Meeting in 2019, SIU will convene a follow-up virtual meeting via SIU’s eLearning platform, SIU Academy. For two half days, world-renowned experts will focus on the latest research in the top three GU cancers: bladder, kidney, and prostate. Registration is free.
 |
 |
Watch this short welcome message from Programme Committee Chair, Dr Peter Black, to see what the SIU 2020 Virtual B2B GU Cancer Triad Meeting is all about and be sure to explore the platform as you get ready to join us online, November 7-8!
The treatment of genitourinary (GU) malignancies has seen tremendous revolution in recent years. Bladder cancer (BCa), renal cell carcinoma (RCC), and prostate cancer (PCa) are the most frequently encountered GU malignancies and represent a heterogeneous population of cancers, in both histology and approach to treatment. These three cancers continue to undergo major paradigm shifts in their respective therapeutic landscapes as we expand our understanding of their underlying molecular and oncogenic mechanisms.
To find out more, click here visit the event page.
Prepared for the live experience? Watch the short video below!
|
|
Happening Now! SIU 2020 on SIU@U Save the Date! Upcoming SIU 360° Webinar
